Print Page | Contact Us | Sign In | Join GSPO Today!
Share |


CE Requirements for NJ Pharmacist



Minimum of thirty (30) credits of which at least ten (10) must be obtained through didactic instruction (in-person, telephone, or electronic instruction; but does not include video-taped instruction) and  three (3) credits shall be obtained in pharmacy law applicable to pharmacy practice in New Jersey.

If a pharmacist is also approved to perform immunizations, two (2) of the thirty (30) CE credits must be completed in immunization related courses.

Beginning with the 2019 biennial renewal, pharmacists must complete one (1) credit of CE programs or topics concerning prescription opioid drugs.

Ten credits of continuing education may be carried over into succeeding biennial period only if such credits were earned during the last six months of the preceding biennial period and were not previously reported.

Pharmacy Technicians

Continuing education is necessary to maintain a high level of continuing education is necessary to maintain a high level of knowledge and skill in pharmacy practice. During the two-year period prior to re-certification, certified pharmacy technicians must participate in at least 20 hours of continuing education (CE), including at least one hour of pharmacy law. Additional CE credits earned cannot be carried over to the next re-certification period.

Collaborative Practice Agreements CE Credits

A pharmacist granted authorization to engage on collaborative drug therapy management shall complete a minimum of ten (10) credits of continuing education every biennial renewal period in each disease(s) or condition(s) covered by the collaborative practice agreement(s) to which he or she is a party, consistent with the requirements of N.J.A.C. 13:39-3A.  However, to the extent that a pharmacist may enter into collaborative practice agreements to treat patients with co-existing, interrelated conditions or diseases, a pharmacist need only complete a total of ten (10) credits in the interrelated conditions or diseases.


For more information visit the NJ Board of Pharmacy

Review the N.J.A.C Chapter 13 HERE

Information on CPE Monitor visit the National Association of Boards of Pharmacy